EQUITY RESEARCH MEMO

Allegiant Health

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)70/100

Allegiant Health is a global manufacturer of over-the-counter (OTC) pharmaceuticals and nutritional supplements, founded in 2017 and headquartered in Nashville, USA. The company operates a robust manufacturing and packaging platform, offering over 200 products under its proprietary HealthA2Z brand as well as private-label and contract manufacturing services. With a strong focus on innovation and quality control, Allegiant has established a significant international presence, particularly in the Chinese-Asian market, where it leverages its capabilities to meet diverse consumer needs. The company's integrated supply chain and scalable production capacity position it as a competitive player in the growing OTC and supplement sectors, serving both branded and white-label customers across multiple geographies.

Upcoming Catalysts (preview)

  • Q3 2026Expansion of HealthA2Z product line into new therapeutic categories (e.g., probiotics, sleep aids)60% success
  • Q2 2026Strategic distribution partnership with a major Asian retailer or e-commerce platform70% success
  • Q4 2026FDA approval for a new OTC monogram drug under the HealthA2Z brand50% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)